There were 72 deals in Q1 2023, a significant drop over Q1 2022’s volume, but still ahead of 2021’s M&A activity. Private Equity activity in the market made up 25% of all deals.

Disclosed M&A deal value also slipped in Q1 2023, accounting for only $220M in total, with no megadeals completed in the quarter.

The top acquirers list of healthtech companies was led by POSaBIT Systems, the only buyer that scored 3 deals in Q1 2023. Following were 4 buyers with 2 deals each, PEs: Eir Partners and Summa Equity, accumulator Constellation Software and another strategic Simitree Healthcare.